RxDoctor Payments Data

Muhammad Masood, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Saint Louis, MONPI 1306166327

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Abbott accounts for 69.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $12,200 and has fallen 96.5% since, to $433 in 2025.

$23,198in general payments, 2019–2025

Across 74 payments — averaging $313.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$16K
  • Medtronic$4K
  • Livanova USA, Inc.$1K
  • Abiomed$1K
  • Edwards Lifesciences$446
  • Bolton Medical Inc$280
  • plus $191 from 2 others
$188,500in research payments, 2019–2025

Across 9 payments — averaging $20,944 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Baxter Healthcare$189K

What the payments were for

  • Consulting fees$11,96152%
  • Speaking & faculty fees$1,9508%
  • Travel & lodging$5,82725%
  • Food & beverage$3,46015%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott42$16,063
Medtronic(2 entities)10$3,928
Livanova USA, Inc.5$1,288
Abiomed8$1,002
Edwards Lifesciences5$446
Bolton Medical Inc2$280
Atricure, Inc.1$124
Baxter Healthcare1$67

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,198 in reported general payments places this provider in the 80th percentile of 113 thoracic surgery (cardiothoracic vascular surgery) providers in Missouri.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Missouri

Medicare billing

Part B allowed, 2024
$144,881
Medicare patients
60
Services billed
178

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin22$169
Chlorhexidine Gluconate16$66

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →